Safety And Efficacy Of A Randomized Phase I Trial To Evaluate Concurrent Or Sequential Ipilimumab, Nivolumab, And Stereotactic Body Radiotherapy In Patients With Stage Iv Non-Small Cell Lung Cancer (Cosinr Study)

S.J. Chmura,C.M. Bestvina,T.G. Karrison,M. Jelinek,A. Juloori,K.B. Pointer, B.E. Onderdonk,P. Hoffman,J.M. Melotek, J. Gordon, J. Ball,A. Pandey,R.R. Weichselbaum,S.P. Pitroda,E.E. Vokes,J.D. Patel

JOURNAL OF CLINICAL ONCOLOGY（2020）

引用 12|浏览42

暂无评分

摘要

9616Background: Stereotactic body radiotherapy (SBRT) provides high rates of treated metastasis control, stimulates innate and adaptive immune pathways, and is safe in patients treated with anti-PD...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要